Elucidating the role of SMAD7 in pancreatic cancer through in vivo studies
Indiana University-Purdue University Indianapolis (IUPUI) === Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of death with a mere 9% survival rate. PDACs harbor KRAS (92-95%) and CDKN2A (90%) mutations, overexpress tyrosine kinase receptors, their ligands, and transforming g...
Main Author: | Savant, Sudha Satish |
---|---|
Other Authors: | Korc, Murray |
Language: | en_US |
Published: |
2017
|
Online Access: | http://hdl.handle.net/1805/14328 |
Similar Items
-
A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival
by: Singh Puneet, et al.
Published: (2011-12-01) -
Nuclear NFATc1/Smad3 complexes in Smad4-deficient pancreatic cancer
by: Hasselluhn, Marie Christin
Published: (2019) -
The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis
by: Carmine Stolfi, et al.
Published: (2013-12-01) - Elucidating the role of Semaphorin 7A in breast cancer
-
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
by: Carmine Stolfi, et al.
Published: (2021-12-01)